Inspire Biotherapeutics

Inspire Biotherapeutics is a biotechnology company. Its mission is to create life-saving gene therapies for monogenic and acquired pulmonary diseases. Its lung-targeted AAV gene therapy platform has demonstrated transduction and long-term expression in lung tissues without affecting other tissue types in disease-relevant animal models. The company is currently working towards initiating the first-in-human clinical trial for a fatal neonatal lung disease. The platform can be applied to cystic fibrosis, interstitial lung disease, pulmonary fibrosis, and other monogenic pulmonary diseases.